BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29739108)

  • 1. Using Blood and Plasma MicroRNAs as a Non-Invasive Biomarker in Patients with Colorectal Cancer.
    Stefanescu H; Muntean D; Pilut C; Diaconu M; Popescu R; Hutanu D; Moise M; Diana L; Nitu R; Cherecheanu AP; Negoita S; Iovan CV; Ungureanu E; Calu V; Ciuca I
    Clin Lab; 2018 Mar; 64(3):257-262. PubMed ID: 29739108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
    Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X; Wu Y; Ji M; Zhang S
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.
    Luo X; Stock C; Burwinkel B; Brenner H
    PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
    Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
    Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNAs Expression as Novel Genetic Biomarker for Early Prediction and Continuous Monitoring in Pulmonary Cancer.
    Nitu R; Rogobete AF; Gundogdu F; Tanasescu S; Boruga O; Sas A; Popovici SE; Hutanu D; Pilut C; Sarau CA; Candea AC; Stan AT; Moise LM
    Biochem Genet; 2017 Aug; 55(4):281-290. PubMed ID: 28070693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
    Sahami-Fard MH; Kheirandish S; Sheikhha MH
    Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA dysregulation in colorectal cancer: a clinical perspective.
    Dong Y; Wu WK; Wu CW; Sung JJ; Yu J; Ng SS
    Br J Cancer; 2011 Mar; 104(6):893-8. PubMed ID: 21364594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Role of MicroRNAs in Colorectal Cancer].
    Kim SW
    Korean J Gastroenterol; 2017 Apr; 69(4):206-211. PubMed ID: 28449421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A panel of microRNA signature in serum for colorectal cancer diagnosis.
    Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
    J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A plasma microRNA panel for early detection of colorectal cancer.
    Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
    Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
    Ng L; Wan TM; Man JH; Chow AK; Iyer D; Chen G; Yau TC; Lo OS; Foo DC; Poon JT; Leung WK; Pang RW; Law WL
    Oncotarget; 2017 Apr; 8(16):27393-27400. PubMed ID: 28404964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
    Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
    Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of microRNA-451a as a Novel Circulating Biomarker for Colorectal Cancer Diagnosis.
    Zhang Z; Zhang D; Cui Y; Qiu Y; Miao C; Lu X
    Biomed Res Int; 2020; 2020():5236236. PubMed ID: 32908896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients.
    Fesler A; Jiang J; Zhai H; Ju J
    Mol Diagn Ther; 2014 Jun; 18(3):303-8. PubMed ID: 24566942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
    Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
    Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.
    Hibner G; Kimsa-Furdzik M; Francuz T
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Dual Role of MicroRNAs in Colorectal Cancer Progression.
    Ding L; Lan Z; Xiong X; Ao H; Feng Y; Gu H; Yu M; Cui Q
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.